Plagrin Plus Tablet 75 mg + 75 mg combines Clopidogrel and Aspirin, two powerful antiplatelet agents used to prevent blood clot formation in patients at risk of cardiovascular and cerebrovascular events. This combination is designed to provide dual antiplatelet therapy (DAPT), which is particularly effective in reducing the risk of heart attacks, strokes, and complications after stent placement.
Clopidogrel works by blocking the P2Y12 ADP receptor on platelets, preventing platelet activation and aggregation. Aspirin complements this effect by irreversibly inhibiting cyclooxygenase-1 (COX-1), reducing the production of thromboxane A2, a substance that promotes platelet clumping. Together, these medications provide synergistic antiplatelet action, offering stronger protection against clot formation than either drug alone.
Plagrin Plus 75 mg + 75 mg is often prescribed for patients with acute coronary syndrome, post-percutaneous coronary intervention (PCI), or high-risk cardiovascular profiles, ensuring consistent daily antiplatelet coverage to prevent recurrent ischemic events. The oral tablet formulation allows convenient once-daily dosing for long-term therapy.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Contains Clopidogrel 75 mg + Aspirin 75 mg per tablet
Provides dual antiplatelet therapy for enhanced cardiovascular protection
Prevents blood clots, heart attacks, strokes, and stent thrombosis
Oral tablet for convenient once-daily administration
Suitable for patients with a high risk of recurrent cardiovascular events
Helps maintain arterial blood flow and reduce ischemic complications
Plagrin Plus Tablet 75 mg + 75 mg is indicated for:
Acute Coronary Syndrome (ACS): Reduces risk of recurrent heart attacks and cardiovascular events
Post-PCI or stent placement: Prevents stent thrombosis and supports long-term vessel patency
Secondary prevention: For patients with a history of myocardial infarction, ischemic stroke, or peripheral artery disease
High-risk cardiovascular patients: To minimize the risk of clot-related complications
This combination therapy should be used under the supervision of a cardiologist or qualified healthcare professional.
The dual mechanism of Plagrin Plus combines the effects of both drugs:
Clopidogrel: Irreversibly inhibits the P2Y12 ADP receptor on platelets, preventing platelet aggregation
Aspirin: Inhibits COX-1 enzyme, reducing thromboxane A2 formation and platelet clumping
Together, these actions prevent thrombus formation in arteries, reduce the risk of ischemic events, and maintain blood flow to vital organs
Recommended dose: 1 tablet orally once daily, with or without food
Take at the same time each day for consistent antiplatelet effect
Dose adjustments may be required in patients with high bleeding risk or liver impairment
Do not stop therapy abruptly, as this increases the risk of heart attack or stroke
Regular follow-up is advised to monitor efficacy and safety
Common side effects:
Gastrointestinal discomfort (nausea, heartburn, indigestion)
Headache or dizziness
Minor bruising or bleeding
Serious but rare side effects:
Severe or internal bleeding
Allergic reactions (rash, swelling, or difficulty breathing)
Gastrointestinal ulcers or hemorrhage
Patients should seek immediate medical attention if they experience unusual bleeding, severe bruising, or symptoms of an allergic reaction.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Use only under medical supervision, particularly in patients with bleeding disorders
Inform your doctor of all medications to avoid interactions, especially with anticoagulants or NSAIDs
Avoid unnecessary trauma or injury during therapy
Not recommended during pregnancy or breastfeeding without medical guidance
Regular monitoring may be necessary for high-risk patients
Store in a cool, dry place below 25°C
Protect from light and moisture
Keep tablets in the original container, tightly closed
Keep out of reach of children.
Login Or Registerto submit your questions to seller
No none asked to seller yet